Skip to main content
. 2025 May 7;26(9):4445. doi: 10.3390/ijms26094445
EM Electromagnetic
G1 phase First gap phase
S phase Synthesis phase
G2 phase Second gap phase
M phase Mitosis phase
ROS Reactive oxygen species
CKIs Cyclin-Dependent Kinase Inhibitors
CDKs Cyclin-Dependent Kinases
CDK4 Cyclin-Dependent Kinase 4
CDK6 Cyclin-Dependent Kinase 6
CDK2 Cyclin-Dependent Kinase 2
ATM Ataxia Telangiectasia Mutated
ATR Ataxia Telangiectasia and Rad3 Related
CHK1 Checkpoint Kinase 1
VGCCs Voltage-gated calcium channels
EMF Electromagnetic field
ELF Extremely low-frequency
PMF Pulsed low-frequency
TFF2 Trefoil Factor 2
VNS Vagus nerve stimulation
MDSCs Myeloid-derived suppressor cells
miRNA microRNA
NSMF Non-sinusoidal magnetic field
RoMEA Relative oxygen metabolic efficiency assay
EIT Electrical impedance tomography
BIS Bioimpedance spectroscopy
HTS High-throughput screening
GBM Glioblastoma
TMZ Temozolomide
PFS Progression-free survival
OS Overall survival
TTP Time to progression
MF Magnetic field
AI Artificial intelligence
MNPs Magnetic nanoparticles
RFA Radiofrequency ablation
LIPUS Low-intensity pulsed ultrasound
LIPUS Low-intensity pulsed ultrasound
MWA Microwave ablation